Senate Substitute for HB 2317 by Committee on Assessment and Taxation - Providing a sales tax exemption for sales of over-the-counter drugs.
Bill status
died
3 of 5 stages cleared
Introduction
Feb 2023
Committee Review
Mar 2024
House Passage
Mar 2023
Senate Passage
Governor
Introduced Feb 7, 2023
Last action Apr 30, 2024
Floor votes · House Mar 29, 2023
How they voted
109–1
Passed
Total votes 110
Mar 29, 2023
D
Democratic34
97% Yea
R
Republican76
100% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
14
Key actions
6
Committee
6
Mar 14, 2024
Upper · Passed
Committee Report recommending substitute bill be passed by Committee on Assessment and Taxation
upper
Apr 4, 2023
Committee
Referred to Committee on Assessment and Taxation
upper
Apr 3, 2023
Introduced
Received and Introduced
upper
Mar 29, 2023
Lower · Passed
Final Action - Passed as amended; Yea: 123 Nay: 1
lower
Mar 28, 2023
Lower · Passed
Committee of the Whole - Be passed as amended
lower
Mar 28, 2023
Lower · Passed
Committee of the Whole - Committee Report be adopted
lower
Mar 28, 2023
Lower · Passed
Committee of the Whole - Now working on
lower
Mar 13, 2023
Lower · Passed
Committee Report recommending bill be passed as amended by Committee on Taxation
lower
Feb 8, 2023
Committee
Referred to Committee on Taxation
lower
Feb 7, 2023
Introduced
Introduced
lower
0 primary · 0 co-sponsors
Sponsors
No sponsor information available.
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 2317
Scope: KS
Hi! I can help you understand HB 2317. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline